This invention relates to spirocyclic piperidines according to Formula (I) and the use of spirocyclic piperidines for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.
SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
申请人:Lupin Limited
公开号:EP3724190B1
公开(公告)日:2022-07-06
US9084794B2
申请人:——
公开号:US9084794B2
公开(公告)日:2015-07-21
[EN] FATTY ACID SYNTHASE INHIBITORS<br/>[FR] INHIBITEURS DE L'ACIDE GRAS SYNTHASE
申请人:GLAXOSMITHKLINE LLC
公开号:WO2013052716A1
公开(公告)日:2013-04-11
Disclosed are compounds having Formula (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R5, R6, R7, R8, R8a, R9 Y, and m are defined herein and methods of using the same.